Mukesh Tiwari
The application of single-use bioreactors is an ever-expanding area
in pharmaceutical bioprocessing. Alice O’Hare, Commissioning
Editor, spoke to three experts in the field and discussed the
current status and future direction of single-use bioreactors in the
bioprocesing community. The rising demand for biosimilars and
bulk quantities of antibodies has pushed pharmaceutical plants to
become more creative and flexible in enhancing their productivity.
How do you predict single-use bioreactors will aid this development?
What are the merits, as well as flaws, of using this type of bioreactor,
as opposed to reusable stainless steel bioreactors? Single-use
bioreactors provide an excellent option to adapt the production
capacity to the market demand.